The European Journal of Health Economics

2002 - 2025

Current editor(s): J.-M.G.v.d. Schulenburg

From:
Springer
Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ)
Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 26, issue 5, 2025

Cost-effectiveness and cost-utility analysis of a nurse-led, transitional care model to improve care coordination for patients with cardiovascular diseases: results from the “Cardiolotse” study pp. 697-710

Marie Coors, Wiebke Schüttig, Katrin C. Reber, Harald Darius, Alfred Holzgreve, Sebastian Karmann, Anica Stürtz, Rebecca Zöller, Saskia Kropp, Petra Riesner and Leonie Sundmacher

The economic costs and consequences of (insufficient) sleep: a case study from Latin America pp. 711-719

María Victoria Anauati, Matías Gómez Seeber, Sebastián Campanario, Walter Sosa Escudero and Diego A. Golombek

Cancer-specific utility: clinical validation of the EORTC QLU-C10D in patients with glioblastoma pp. 721-733

Simone Seyringer, Micha J. Pilz, Andrew Bottomley, Madeleine T. King, Richard Norman and Eva M. Gamper

Cost-utility of cochlear implantation in single-sided deafness and asymmetric hearing loss: results of a randomized controlled trial pp. 735-744

Mathieu Marx, Michaël Mounié, Isabelle Mosnier, Frédéric Venail, Michel Mondain, Alain Uziel, David Bakhos, Emmanuel Lescanne, Yann N’Guyen, Daniele Bernardeschi, Olivier Sterkers, Benoit Godey, Gwenaëlle Creff, Sébastien Schmerber, Nicolas-Xavier Bonne, Christophe Vincent, Bernard Fraysse, Olivier Deguine and Nadège Costa

Cost-effectiveness of TAVI in the United Kingdom: a long-term analysis based on 4-year data from the Evolut Low Risk Trial pp. 745-755

Daniel J. Blackman, Anne M. Ryschon, Sophie Barnett, Abigail M. Garner, John K. Forrest, Michael R. Reardon and Jan B. Pietzsch

Regional variation in the utilization of nursing home care in Germany pp. 757-776

Annika Herr, Maximilian Lückemann and Amela Saric-Babin

Exploring the social value and design preferences for a home-based dementia community program in Australia pp. 777-795

Sabrina Lenzen, Brenda Gannon, Richard Norman, Sally Bennett, Lindy Clemson and Laura Gitlin

Expensive today but cheaper tomorrow: lifetime costs of an active middle ear implant compared to alternative treatment options pp. 797-816

Markus Krohn, Klaas Kiesewetter, Annika Buchholz, Bettina Schlick, Susan Busch, Thomas Lenarz, Anke Lesinski-Schiedat, Hannes Maier, Cornelia Batsoulis, Michael Urban and Steffen Flessa

The effect of workload on primary care doctors on referral rates and prescription patterns: evidence from English NHS pp. 817-837

Hanifa Pilvar and Toby Watt

Can wage changes solve the labour crisis in the National Health Service? pp. 839-853

Xingzuo Zhou, Jolene Skordis, Junjian Yi, Yiang Li, Jonathan Clarke and Hongkun Zhang

Interprofessional team-based primary care practice and preventive cancer screening: evidence from Family Health Teams in Ontario, Canada pp. 855-868

Yihong Bai, Jennifer Reid, Steven Habbous, Rose Anne Devlin, Liisa Jaakkimainen and Sisira Sarma

The economic burden of asthma in Italy: evaluating the potential impact of different treatments in adult patients with severe eosinophilic asthma pp. 869-876

Matteo Scortichini, Francesco Saverio Mennini, Andrea Marcellusi, Martina Paoletti, Carlo Tomino and Paolo Sciattella

Volume 26, issue 4, 2025

Pricing combination products: not how but who? pp. 537-540

Adrian Towse, Andrew Briggs and Lotte Steuten

Does implementing opt-out solve the organ shortage problem? Evidence from a synthetic control approach pp. 541-560

Selina Schulze Spuentrup

Strategic behavior and entry deterrence by branded drug firms: the case of authorized generic drugs pp. 561-575

Lu Yao and Mengde Liu

Comparison of the EQ-5D-Y and the CHU-9D instruments in a general child population based on self-reports and proxy-reports pp. 577-588

Yan Li, Yanqiu Chen, Jize Sun, Mingyu Jiang, Aixia Ma, Tiantian Tao and Pingyu Chen

Comparison of four approaches in eliciting health state utilities with SF-6Dv2 pp. 589-604

Hosein Ameri and Thomas G. Poder

The societal cost of ‘unwanted’ loneliness in Spain pp. 605-617

Bruno Casal, Eva Rodríguez-Miguez and Berta Rivera

Assessing a decade of leukaemia-related premature mortality costs: impact on productivity loss in Spain pp. 619-625

Josep Darbà, Meritxell Ascanio and Ainoa Agüera

Comparing EQ-5D-5L, PROPr, SF-6D and TTO utilities in patients with chronic skin diseases pp. 627-639

Ákos Szabó, Valentin Brodszky and Fanni Rencz

Adverse selection and consumer inertia: empirical evidence from the Dutch health insurance market pp. 641-651

Ramsis R. Croes, Frederik T. Schut and Marco Varkevisser

Benefits beyond health in the willingness to pay for a quality-adjusted life-year pp. 653-670

Linda M. Vries, Werner B. F. Brouwer and Pieter H. M. Baal

Comparing the measurement properties of the EQ-5D-5 L, SF-6Dv2, QLU-C10D and FACT-8D among survivors of classical Hodgkin’s lymphoma pp. 671-682

Richard Huan Xu, Zuyi Zhao, Tianxin Pan, Andrea Monteiro, Hongfei Gu and Dong Dong

Drug pricing models, no ‘one-size-fits-all’ approach: a systematic review and critical evaluation of pricing models in an evolving pharmaceutical landscape pp. 683-696

Evert A. Manders, Sibren den Berg, Saco J. Visser and Carla E. M. Hollak

Volume 26, issue 3, 2025

Psychometric validation of the Chinese versions of EQ-5D-Y-3L and the experimental EQ-TIPS in children and adolescents with COVID-19 pp. 337-351

Wenjing Zhou, Yaqin Li, Jan Busschbach, Michael Herdman, Zhihao Yang and Yanming Lu

The formal care costs of dementia: a longitudinal study using Swedish register data pp. 353-361

Jennifer Zilling, Ulf-G. Gerdtham, Johan Jarl, Sanjib Saha and Sofie Persson

A critical review of the use of R2 in risk equalization research pp. 363-375

Wynand P. M. M. Ven and Richard C. Kleef

Time value of informal care of people with alzheimer’s disease in Spain: a population-based analysis pp. 377-402

Vilaplana-Prieto C and Oliva-Moreno J

Testing four cognition bolt-on items to the EQ-5D in a general Chinese population pp. 403-411

Meixia Liao, Hongyan Wu, Zhihao Yang, Yan Huang, Mathieu F. Janssen, Gouke Bonsel and Nan Luo

Cost-effectiveness of hydroxychloroquine retinopathy screening: the current guideline versus no screening and reduced regimens pp. 413-425

Sara W. Quist, Sophie te Dorsthorst, Roel D. Freriks, Maarten J. Postma, Carel B. Hoyng and Freekje Asten

Cost effectiveness of a GP delivered medication review to reduce polypharmacy and potentially inappropriate prescribing in older patients with multimorbidity in Irish primary care: the SPPiRE cluster randomised controlled trial pp. 427-454

Paddy Gillespie, Frank Moriarty, Susan M. Smith, Anna Hobbins, Sharon Walsh, Barbara Clyne, Fiona Boland, Tara McEnteggart, Michelle Flood, Emma Wallace and Caroline McCarthy

Trends in NICE technology appraisals of non-small cell lung cancer drugs over the last decade pp. 455-471

Lotte Westerink, Sharon Wolters, Guiling Zhou, Arjan Postma, Cornelis Boersma, Job Frank Martien Boven and Maarten Jacobus Postma

The added value of the cognition, dining, gastrointestinal problems, sleep and tiredness bolt-on dimensions to the EQ-5D-5L in patients with coeliac disease pp. 473-485

M. Mercédesz Angyal, Mathieu F. Janssen, Péter L. Lakatos, Valentin Brodszky and Fanni Rencz

Valuation of the EQ-5D-3L in Jordan pp. 487-501

Abeer Rabayah, Bram Roudijk, Fredrick Dermawan Purba, Fanni Rencz, Saad Jaddoua and Uwe Siebert

Should Scotland provide genome-wide sequencing for the diagnosis of rare developmental disorders? A cost-effectiveness analysis pp. 503-512

Michael Abbott, Mandy Ryan, Rodolfo Hernández, Lynda McKenzie, Sebastian Heidenreich, Lynne Hocking, Caroline Clark, Morad Ansari, David Moore, Anne Lampe, Ruth McGowan, Jonathan Berg and Zosia Miedzybrodzka

An assessment of the implications of distribution remuneration and taxation policies on the final prices of prescription medicines: evidence from 35 countries pp. 513-536

Giovanny Leon, Christophe Carbonel, Aparajit Rampuria, Ravindra Singh Rajpoot, Parth Joshi and Panos Kanavos

Volume 26, issue 2, 2025

Setting incentives right with long-term risk adjustment pp. 147-151

Simon Reif, Sabrina Schubert and Achim Wambach

Long-term returns to local health-care spending pp. 153-182

Jakub Červený and Jan C. van Ours

Monetary value of health—a practical decision-making framework combining equity considerations and WTP pp. 183-198

Elizabeta Ribarić, Ismar Velić and Ana Bobinac

Workload and short sickness absences in a cohort of Finnish hospital employees pp. 199-222

Tero Kuusi, Martti Kulvik, Mikko Härmä and Annina Ropponen

Population normative data for OxCAP-MH capability scores pp. 223-231

Péter György Balázs, Agata Łaszewska, Judit Simon and Valentin Brodszky

Does medial tourism promote growth in healthcare sector? pp. 233-241

Hassan Gholipour Fereidouni and Kourosh Esfandiar

The hidden cost of sophistication: economic complexity and obesity pp. 243-265

Ronald Djeunankan, Sosson Tadadjeu, Henri Njangang and Ummad Mazhar

A budget impact analysis of a digital monitoring solution in patients treated with oral anticancer agents: a medico-economic analysis of the randomized phase 3 CAPRI trial pp. 267-273

Etienne Minvielle, Henri Leleu, Marc Masseti, Arlindo Ferreira, Gérard Pouvourville, Mario Di Palma and Florian Scotté

The EQ-5D-3L valuation study for Bermuda: using an on-line EQ-VT protocol pp. 275-297

Henry Bailey, Bram Roudijk and Ricky Brathwaite

Incentivizing adherence to pre-exposure prophylaxis for HIV prevention: a randomized pilot trial among male sex workers in Mexico pp. 299-311

Omar Galarraga, Marta Wilson-Barthes, Carlos Chivardi, Nathalie Gras-Allain, Fernando Alarid-Escudero, Monica Gandhi, Kenneth H. Mayer and Don Operario

Migration-related determinants of health-care service utilization among persons with a direct migration background in Germany: an exploratory study based on the German Socio-Economic Panel (SOEP) pp. 313-323

Thomas Grochtdreis, Hans-Helmut König and Judith Dams

Economies of scope in the Norwegian public hospital sector pp. 325-335

Nils Arne Lindaas, Kjartan Sarheim Anthun, Sverre Kittelsen and Jon Magnussen

Volume 26, issue 1, 2025

Obesity epidemic in European countries: from an unaddressed risk factor to a medicalized disease? pp. 1-5

Livio Garattini and Giovanni Fattore

The performance of the EQ-HWB-S as a measure of quality-of-life of caregivers in families that have experienced adverse events pp. 7-21

Cate Bailey, Kim Dalziel, Leanne Constable, Nancy J. Devlin, Harriet Hiscock, Helen Skouteris and Tessa Peasgood

Economic evaluation of intensive home treatment in comparison to care as usual alongside a randomised controlled trial pp. 23-34

Ansam Barakat, Jurgen E. Cornelis, Jack J. M. Dekker, Nick M. Lommerse, Aartjan T. F. Beekman and Matthijs Blankers

Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden pp. 35-48

Thomas Sejersen, Sophie Graham, Anne-Berit Ekström, Anna-Karin Kroksmark, Marta Kwiatkowska, Michael L. Ganz, Nahila Justo, Karl Gertow and Alex Simpson

Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system pp. 49-62

Silvia Fenix-Caballero, Adrián Sanchez-Vegas, Emilio Jesús Alegre Del-Rey, David Epstein, Leticia Garcia-Mochon and Antonio Olry de Labry Lima

Mapping functions for the PHQ-9 and GAD-7 to generate EQ-5D-3L for economic evaluation pp. 63-70

Clara Mukuria, Matthew Franklin and Sebastian Hinde

The impact of different perspectives on the cost-effectiveness of remote patient monitoring for patients with heart failure in different European countries pp. 71-85

Hamraz Mokri, Pieter Baal and Maureen Rutten- van Mölken

Is there a link between health care utilisation and subjective well-being? An exploratory study among older Danes pp. 87-93

Maiken Skovrider Aaskoven, Trine Kjær and Dorte Gyrd-Hansen

Do institutions matter for citizens’ health status? Empirical evidence from Italy pp. 95-115

M. Alessandra Antonelli and Giorgia Marini

Costs associated with insufficient physical activity in Germany: cross-sectional results from the baseline examination of the German national cohort (NAKO) pp. 117-128

Sophie Gottschalk, Hans-Helmut König, Andrea Weber, Michael F. Leitzmann, Michael J. Stein, Annette Peters, Claudia Flexeder, Lilian Krist, Stefan N. Willich, Katharina Nimptsch, Tobias Pischon, Sylvia Gastell, Karen Steindorf, Florian Herbolsheimer, Nina Ebert, Karin B. Michels, Anja Dorrn, Volker Harth, Nadia Obi, André Karch, Henning Teismann, Henry Völzke, Claudia Meinke-Franze, Leon Klimeck, Teresa L. Seum and Judith Dams

Cost-effectiveness analysis of procalcitonin and lung ultrasonography guided antibiotic prescriptions in primary care pp. 129-139

Giulio Cisco, Armando N. Meier, Nicolas Senn, Yolanda Mueller, Andreas Kronenberg, Isabella Locatelli, José Knüsli, Loïc Lhopitallier, Noemie Boillat-Blanco and Joachim Marti

Letter to the Editor: Lazzaro responds to Kennedy et al pp. 141-142

Carlo Lazzaro

Correction: AOTMiT reimbursement recommendations compared to other HTA agencies pp. 143-146

Aneta Mela, Dorota Lis, Elżbieta Rdzanek, Janusz Jaroszyński, Marzena Furtak-Niczyporuk, Bartłomiej Drop, Tomasz Blicharski and Maciej Niewada